1. Home
  2. YEXT vs FDMT Comparison

YEXT vs FDMT Comparison

Compare YEXT & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yext Inc.

YEXT

Yext Inc.

N/A

Current Price

$7.72

Market Cap

644.4M

Sector

Technology

ML Signal

N/A

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

SELL

Current Price

$11.30

Market Cap

695.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
YEXT
FDMT
Founded
2006
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
644.4M
695.3M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
YEXT
FDMT
Price
$7.72
$11.30
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
★ $28.09
AVG Volume (30 Days)
697.1K
★ 960.5K
Earning Date
12-07-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 131.82
18.79
EPS
★ 0.15
N/A
Revenue
★ $170,201,000.00
$85,209,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.04
$44.20
P/E Ratio
$51.10
★ N/A
Revenue Growth
N/A
★ 230194.60
52 Week Low
$3.27
$6.96
52 Week High
$9.03
$16.93

Technical Indicators

Market Signals
Indicator
YEXT
FDMT
Relative Strength Index (RSI) 62.47 42.56
Support Level $7.05 $8.43
Resistance Level $7.96 $11.96
Average True Range (ATR) 0.30 0.93
MACD -0.01 0.04
Stochastic Oscillator 62.81 13.10

Price Performance

Historical Comparison
YEXT
FDMT

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: